Insider NameBuy/SellCompany NameTickerAmountShares Change
Oct 02, 2020Oct 06, 2020Silverstein Jonathan
Dir
10%
BuyArcutis Biotherapeutics, Inc.ARQT$25$12M+35.47%
Feb 03, 2020Feb 04, 2020Silverstein Jonathan
Dir
10%
BuyArcutis Biotherapeutics, Inc.ARQT$17$10M+47.97%
Mar 02, 2018Mar 07, 2018Silverstein Jonathan
Dir
SellGlaukos CorpGKOS$32.02$27M-0
Jan 30, 2018Jan 30, 2018Silverstein Jonathan
Dir
10%
BuyRestorbio, Inc.TORC$15$8M+9.94%
Aug 31, 2017Sep 06, 2017Silverstein Jonathan
Dir
SellGlaukos CorpGKOS$38.73$22M-98.66%
Aug 15, 2017Aug 17, 2017Silverstein Jonathan
Dir
SellGlaukos CorpGKOS$37.93$12M-96.05%
Mar 10, 2017Mar 14, 2017Silverstein Jonathan
Dir
SellGlaukos CorpGKOS$45.33$17M-95.88%
Mar 03, 2017Mar 07, 2017Silverstein Jonathan
Dir
SellGlaukos CorpGKOS$47.05$3M-73.56%
Aug 10, 2016Aug 13, 2016Silverstein Jonathan
Dir
SellGlaukos CorpGKOS$33.69$10M-93.44%
Aug 03, 2016Aug 05, 2016Silverstein Jonathan
Dir
SellGlaukos CorpGKOS$30.59$13M-94.80%
Jul 25, 2016Jul 25, 2016Silverstein Jonathan
Dir
10%
BuyAudentes Therapeutics, Inc.BOLD$15$500,010+0.69%
Mar 26, 2015Mar 30, 2015Silverstein Jonathan
Dir
SellIntercept Pharmaceuticals IncICPT$286.75$45M-12.31%
Mar 23, 2015Mar 25, 2015Silverstein Jonathan
Dir
SellIntercept Pharmaceuticals IncICPT$274.41$57M-13.99%
Aug 25, 2014Aug 28, 2014Silverstein Jonathan
Dir
SellIntercept Pharmaceuticals IncICPT$298.06$33M-6.97%
Aug 14, 2014Aug 19, 2014Silverstein Jonathan
Dir
SellIntercept Pharmaceuticals IncICPT$299.82$18M-3.62%
Jul 22, 2014Jul 24, 2014Silverstein Jonathan
Dir
10%
BuyRoka Bioscience, Inc.ROKA$12$5M+92.66%
Apr 09, 2014Apr 12, 2014Silverstein Jonathan
Dir
SellIntercept Pharmaceuticals IncICPT$320$26M-4.68%
Nov 20, 2013Nov 21, 2013Silverstein Jonathan
Dir
10%
BuyRelypsa IncRLYP$11$8M+6.68%
Oct 21, 2013Oct 24, 2013Silverstein Jonathan
Dir
SellIntercept Pharmaceuticals IncICPT$62.5$3M-2.26%
Oct 15, 2013Oct 18, 2013Silverstein Jonathan
Dir
SellIntercept Pharmaceuticals IncICPT$62.5$24M-17.49%
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.